by [email protected] | May 16, 2019 | Endocrine, Publication
Abstract Authors: Zhou FL, Xie L, Pan C, Wang Y, Vaidya N, Ye F, Preblick R, Meneghini L. This study examines the relationship between glycated haemoglobin (A1C) levels and treatment persistence with, or time to discontinuation of, basal insulin in patients with type...
by [email protected] | May 15, 2019 | Endocrine, Publication
Abstract Authors: Dalal MR, Kazemi M, Ye F, Xie L. Introduction: Hypoglycemia and fear of hypoglycemia may contribute to basal insulin discontinuation, poor glycemic control, and increased healthcare burden in patients with type 2 diabetes (T2D). This study aimed...
by [email protected] | May 14, 2019 | Endocrine, Publication
Abstract Authors: Brekke L, Buysman E, Grabner M, Ke X, Xie L, Baser O, Wei W Background: Determining characteristics of patients likely to benefit from a particular treatment could help physicians set personalized targets. Objectives: To use decomposition...
by [email protected] | May 13, 2019 | Endocrine, Publication
Abstract Authors: Wei W, Buysman E, Grabner M, Xie L, Brekke L, Ke X, Chu JW, Levin PA. Aims: Examine real-world outcomes in patients with type 2 diabetes mellitus (T2DM) initiating injectable therapy as part of the Initiation of New Injectable Treatment...
by [email protected] | May 12, 2019 | Endocrine, Publication
Abstract Authors: Cai J, Wang Y, Baser O, Xie L, Chow W. Objectives: Non-adherence and non-persistence to anti-hyperglycemic agents are associated with worse clinical and economic outcomes in patients with type 2 diabetes. This study evaluated treatment...
by [email protected] | May 11, 2019 | Endocrine, Publication
ABSTRACT Authors: Dalal MR, Xie L, Baser O, DiGenio A. Objective: To evaluate real-world outcomes in patients with type 2 diabetes mellitus (T2DM) receiving basal insulin who initiate add-on therapy with a rapid-acting insulin (RAI) or a glucagon-like peptide 1...
